Evidence map›Paper›PMID 40437235›Full record

ArticleCell death and differentiation2025

DNA damage response defects induced by the formation of TDP-43 and mutant FUS cytoplasmic inclusions and their pharmacological rescue.

Stefania Modafferi, Stefania Farina, Francesca Esposito, Ornella Brandi, Michela Di Salvio, Ilaria Della Valle, Sara D'Uva, Eveljn Scarian, Giada Cicio, Adelaide Riccardi and 11 more

Abstract read
In one paragraph

Article in Cell death and differentiation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Proteomic Identification of ALDOA as a Pathogenic TDP-43 Interaction Partner in ALS.Degenerative neurological and neuromuscular disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Stefania Modafferi *Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy.ORCID 0000-0002-5669-860X
Stefania Farina *Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy.
Francesca Esposito *Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy.
Ornella Brandi *Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy.
Michela Di SalvioInstitute of Molecular Biology and Pathology, CNR, Rome, Italy.
Ilaria Della VallePhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome Tor Vergata, Rome, Italy.
Sara D'UvaDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, Rome, Italy.
Eveljn ScarianCellular Models and Neuroepigenetics Unit, IRCCS Mondino Foundation, Pavia, Italy.
Giada CicioIFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.
Adelaide RiccardiInstitute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy.
Federica PisatiCogentech Società Benefit srl, Milan, Italy.
Anna GarbelliInstitute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy.
Tiziana SantiniDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, Rome, Italy.
Orietta PansarasaCellular Models and Neuroepigenetics Unit, IRCCS Mondino Foundation, Pavia, Italy.
Mariangela MorlandoDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, Rome, Italy.
Nadia D'AmbrosiDepartment of Biology, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0002-6646-7653
Mauro CozzolinoInstitute of Translational Pharmacology, CNR, Rome, Italy.ORCID 0000-0003-0342-8961
Gianluca CestraInstitute of Molecular Biology and Pathology, CNR, Rome, Italy.
Fabrizio d'Adda di FagagnaInstitute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy.ORCID 0000-0002-9603-5966
Ubaldo GioiaInstitute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy. ubaldo.gioia@cnr.it.ORCID 0000-0002-4993-5283
Sofia FranciaInstitute of Molecular Genetics "Luigi Luca Cavalli-Sforza", National Research Council (CNR), Pavia, Italy. sofia.francia@cnr.it.ORCID 0000-0002-4578-9442

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) AIRC 5×1000Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) AIRC-IG(21762)Consiglio Nazionale delle Ricerche (National Research Council) DBA.AD005.225-NUTRAGE-FOE2021Consiglio Nazionale delle Ricerche (National Research Council) Flagship Project InteromicsEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) TELORNAGING-835103Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS) 2016 DDRNA&ALSFondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS) 2021 DDR&ALSFondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS) SwitchALSFondazione Telethon (Telethon Foundation) GGP17111Istituto Superiore di Sanità (ISS) RIPREI2023_7c8ae10d783cMinistero della Salute (Ministry of Health, Italy) Ricerca Corrente 2022 - 2024Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) CN00000041 CN3 RNAMinistero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) MNESYS (PE0000006)Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) PNRR-CN3Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) PRIN 2020 CXFL4TRegione Lombardia (Region of Lombardy) POR FESR 2014-2020
6 · The paper itself

Abstract

Formation of cytoplasmic inclusions (CIs) of TDP-43 and FUS, along with DNA damage accumulation, is a hallmark of affected motor neurons in Amyotrophic Lateral Sclerosis (ALS). However, the impact of CIs on DNA damage response (DDR) and repair in this pathology remains unprobed. Here, we show that CIs of TDP-43 and FUS

Indexed as

DNA-Binding ProteinsDNA DamageInclusion BodiesRNA-Binding Protein FUSAmyotrophic Lateral SclerosisAnimalsAtaxia Telangiectasia Mutated ProteinsDNA Breaks, Double-StrandedDNA RepairHumansMiceMutationAtaxia Telangiectasia Mutated ProteinsDNA-Binding ProteinsRNA-Binding Protein FUSTARDBP protein, human

Identifiers

PMID40437235
PMCPMC12669588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.